Point72 Asset Management
DPLO

Point72 Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Point72 Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-939,562
Closed -$18.9M – 1270
2018
Q1 		$18.9M Buy
939,562
+877,922
+1,424% +$20.5M 0.08% 300
2017
Q4 		$1.24M Sell
61,640
-335,560
-84% -$6.6M 0.01% 783
2017
Q3 		$8.23M Buy
+397,200
New +$6.72M 0.04% 440

Other funds holding DPLO

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management's DPLO Position: Q2 2018 in Review

Point72 Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 939,562 shares — an estimated $18.9M sold.

Point72 Asset Management first reported a position in DPLO in Q3 2017 and held it in 3 quarters. The position peaked at $18.9M in Q1 2018. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • Point72 Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • Point72 Asset Management sold 939,562 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $18.9M.
  • Point72 Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2017 and held it in 3 quarters.
  • Point72 Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $18.9M in Q1 2018.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Point72 Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.